The use of serum and urine oestriol measurements in the management of high-risk pregnancies is now well established. Nearly all of the oestriol present in the maternal serum or urine is derived from placental conversion of steroid precursors produced by the fetus. Therefore, maternal serum or urine oestriol concentrations reflect, primarily, the status of the fetoplacental unit. Very low third trimester oestriol levels have been associated with several clinical situations'-: (a) iatrogenic effects (antibiotics, cortisone and other drugs), (b) gross disturbances of the maternal enterohepatic circulation, (c) severe intrauterine growth retardation, (d) anencephaly, (e) fetal death, (f) primary fetal adrenal hypoplasia and (g) placental steroid sulphatase deficiency (SSD).
Conditions (a) to (e) may be differentiated by the history and clinical examination. However, the latter two situations, (J) and (g) are more difficult to distinguish from one another. Fetal adrenal hypoplasia is associated with a high neonatal mortality rate as the newborn infants are likely to be at risk from adrenal insufficiency. In pregnancies with SSD there is a high incidence of difficult labourmany requiring caesarean section. Both conditions result in very low oestrogen production in the presence of apparently normal fetal growth and development. Fortunately, biochemical tests are useful in discriminating between these two conditions and the following case study illustrates their use.
Accepted for publication 13 April 1982 Case report A 25-year-old primigravida failed to gain weight during the 31st and 32nd weeks of pregnancy. The 24-hour urinary oestrogen output was found to be low and she was admitted for further investigation. Apart from the oestrogens, routine blood (albumin, total protein, electrolytes, urea, calcium, phosphate, liver function tests and creatinine) and urine (protein, glucose and creatinine clearance) investigations were normal. Serial urinary oestrogens over a five-day period were consistently low (average concentration 7 p.mol/24h, reference range 40-150 ,umol/24h). The patient continued to be clinically normal with a very active fetus and began to gain weight again. A serum oestriol at 34 wk was 10( 7 nmol/l (reference range 15-56 ,umol/24h) suggesting that SSD rather than fetal adrenal hypoplasia was the probable cause of the low oestrogen excretion. 4 The patient was sent home pending confirmation of the diagnosis.
The excretion of steroid sulphates in maternal urine (Table 1) was raised when compared with normal pregnancies (gas chromatographic determination by Dr J Honour at the Clinical Research Centre, Harrow), but it was within the laboratory ranges for these compounds in 10 previous cases of confirmed SSD.5 Further oestriol determinations between 37 and 39 weeks were all less than 20 ,u mol/24h and the pregnancy progressed normally.
At 39 wk gestation the patient was readmitted to hospital with regular contractions and ruptured membranes. She gave birth to a 3310 g boy after a four-hour labour. The infant had an Apgar score of 9 at minute and appeared healthy. The post-natal course was uneventful and mother and child were discharged five days later.
The mother's previous medical history was unremarkable but her brother has a dry scaly skin condition ('' ichthyosis) which the family believe to be inherited from her great-grandfather. The child's progress is being followed to see if he develops this condition.
Discussion
Placental oestrogens are produced by the metabolism of dehydroepiandrosterone sulphate (DHAS) originating from the mother and the fetus,and 16a-hydroxydehydroepiandrosterone sulphate (16-OHDHAS), originating predominantly from the fetus. In the first step of oestriol synthesis the sulphated conjugates are hydrolysed through the action of the microsomal enzyme 3f-yl steroid sulphatase (sterol sLIlphate sulphohydrolase, EC 3.1.6.2.). In the case of deficient activity of this enzyme the hydrolysis cannot take place and the formation of oestriol is impaired.6
The first case of SSD-then recognised as a placental sulphatase deficiency-was reported by France and The ichthyosis itself appears to be caused by the deficiency of the enzyme arylsulphatase C in the epidermis, although its role in the process of keratinisation is still unknown. Ichthyosis has now been reported in association with one-fifth of the cases of SSD. This association with a known X-linked disorder and the very high male:female ratio strongly suggests that SSD is an X-linked disorder, although autosomal dominant transmission with sex-linked expression cannot be totally excluded.6 Many cases of SSD probably go undetected since affected pregnancies follow a normal antenatal course. It has been estimated that as many as one in 3000 pregnancies is affected.26 Routine screening of all third trimester pregnancies for oestriol excretion would probably reveal many more cases of SSD and perhaps other associated defects of steroid metabolism.
The finding of a consistently low maternal urinary or plasma oestriol in company with apparently normal fetal development should alert the chemical pathologist/biochemist to the possibility of SSD and the need for confirmatory tests.
